Document is current

Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection

Crossref DOI link: https://doi.org/10.1007/s12072-015-9668-3

Published Online: 2015-11-05

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy